Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2
Clinical trial NCT02059759 · COMPLETED
Trial details
- NCT number
- NCT02059759
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-05-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.